The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

Author： van der Stelt M.   Di Marzo V.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.480, Iss.1, 2003-11, pp. : 133-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Involvement of the Endocannabinoid System in Motor Disorders

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 175-182

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders

By  

Current Pharmaceutical Design, Vol. 6, Iss. 17, 2000-11 ,pp. : 1755-1776

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals

By  

Current Pharmaceutical Design, Vol. 20, Iss. 13, 2014-04 ,pp. : 2072-2088

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the endocannabinoid system in treating brain disorders

By Bahr Ben A   Karanian David A   Makanji Sagar S   Makriyannis Alexandros  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 4, 2006-04 ,pp. : 351-365

Informa Healthcare

Access to resources Recommend Favorite

The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 451-458

Bentham Science Publishers

Access to resources Recommend Favorite